Recent Finacing
Recent Raise
Flavocure develops non-cannabinoid flavonoid-derived oncology therapeutics from cannabis, advancing two patent-pending molecules (including Cresorol with FDA orphan designation for AML), conducting preclinical studies and institutional collaborations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor